Therapy Area topics

Cardiovascular

Vantage logo

Gossamer unravels

The group's pulmonary arterial hypertension therapy might work in sicker patients, but investors are unwilling to stick around.

Central Nervous System

Vantage logo

Novartis trims its pipeline

Discontinuations for branaplam, iptacopan and Piqray could increase pipeline scepticism, but more pruning is coming.

Diabetes

Vantage logo

Astrazeneca gets personal

A collaboration this week with the blood testing specialist Capitainer underlines the big pharma’s ambition to have a diagnostic linked with every pipeline project.

Digital Health

Oncology

Vantage logo

Novocure aims to plough a new field

Lung cancer approval for the group’s electric fields-based therapy could come this year, but Novocure has broader solid tumour ambitions.

Respiratory

Vantage logo

Astrazeneca gets personal

A collaboration this week with the blood testing specialist Capitainer underlines the big pharma’s ambition to have a diagnostic linked with every pipeline project.

Various